These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29114905)

  • 41. Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma.
    Lambiase A; Bonini S; Rasi G; Coassin M; Bruscolini A; Bonini S
    Arch Ophthalmol; 2003 May; 121(5):615-20. PubMed ID: 12742837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful drug treatment of immune reconstitution disease with the leukotriene receptor antagonist, montelukast: a clue to pathogenesis?
    Lipman MC; Carding SK
    AIDS; 2007 Jan; 21(3):383-4. PubMed ID: 17255752
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy of montelukast, a leukotriene receptor antagonist, for the treatment of dysmenorrhea: a prospective, double-blind, randomized, placebo-controlled study.
    Fujiwara H; Konno R; Netsu S; Odagiri K; Taneichi A; Takamizawa S; Ohwada M; Suzuki M
    Eur J Obstet Gynecol Reprod Biol; 2010 Feb; 148(2):195-8. PubMed ID: 19944517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Montelukast for mild and exercise-induced asthma.
    Adelman A
    J Fam Pract; 1998 Nov; 47(5):335. PubMed ID: 9834763
    [No Abstract]   [Full Text] [Related]  

  • 45. Leukotriene D4 inhalation challenge for predicting short-term efficacy of montelukast: a pilot study.
    Guan WJ; Shi X; Zheng JP; Gao Y; Jiang CY; Xie YQ; Liu QX; Zhu Z; Guo E; An JY; Yu XX; Liu WT; Zhong NS
    Clin Respir J; 2015 Jan; 9(1):111-20. PubMed ID: 24506412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast.
    Hani N; Hartmann K; Casper C; Peters T; Schneider LA; Hunzelmann N; Scharffetter-Kochanek K
    Acta Derm Venereol; 2000 May; 80(3):229. PubMed ID: 10954230
    [No Abstract]   [Full Text] [Related]  

  • 47. Anti-inflammatory effects of montelukast in mild cystic fibrosis.
    Schmitt-Grohé S; Eickmeier O; Schubert R; Bez C; Zielen S
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):599-605. PubMed ID: 12487226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The leukotriene receptor antagonist montelukast and aortic stenosis.
    Bäck M; Yin L; Nagy E; Ingelsson E
    Br J Clin Pharmacol; 2013 Jan; 75(1):280-1. PubMed ID: 22616719
    [No Abstract]   [Full Text] [Related]  

  • 49. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
    Robinson DS; Campbell D; Barnes PJ
    Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Montelukast treatment of urticaria.
    McBayne TO; Siddall OM
    Ann Pharmacother; 2006 May; 40(5):939-42. PubMed ID: 16670370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of leukotriene receptor antagonism in the postoperative management of chronic rhinosinusitis.
    Yelverton JC; Holmes TW; Johnson CM; Gelves CR; Kountakis SE
    Int Forum Allergy Rhinol; 2016 Mar; 6(3):243-7. PubMed ID: 26834076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of interstitial cystitis with montelukast, a leukotriene D(4) receptor antagonist.
    Bouchelouche K; Nordling J; Hald T; Bouchelouche P
    Urology; 2001 Jun; 57(6 Suppl 1):118. PubMed ID: 11378098
    [No Abstract]   [Full Text] [Related]  

  • 53. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
    Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
    J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Montelukast: a novel therapeutic option in eosinophilic peritonitis.
    Forbes TA; Lunn AJ
    Pediatr Nephrol; 2014 Jul; 29(7):1279-82. PubMed ID: 24346824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Montelukast (singulair) for allergic rhinitis.
    Med Lett Drugs Ther; 2003 Mar; 45(1152):21-2. PubMed ID: 12637892
    [No Abstract]   [Full Text] [Related]  

  • 56. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF
    J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The efficacy of montelukast monotherapy in moderate persistent asthmatic children.
    Igde M; Anlar FY
    Iran J Allergy Asthma Immunol; 2009 Sep; 8(3):169-70. PubMed ID: 20124610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma.
    Montuschi P; Mondino C; Koch P; Ciabattoni G; Barnes PJ; Baviera G
    Chest; 2007 Dec; 132(6):1876-81. PubMed ID: 18079221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Montelukast Does not Maintain Symptom Remission After Topical Steroid Therapy for Eosinophilic Esophagitis.
    Alexander JA; Ravi K; Enders FT; Geno DM; Kryzer LA; Mara KC; Smyrk TC; Katzka DA
    Clin Gastroenterol Hepatol; 2017 Feb; 15(2):214-221.e2. PubMed ID: 27650328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pilot study examining the role of zileuton in atopic dermatitis.
    Woodmansee DP; Simon RA
    Ann Allergy Asthma Immunol; 1999 Dec; 83(6 Pt 1):548-52. PubMed ID: 10619348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.